Immune thrombocytopenia (ITP) trials in Hong Kong

6 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  Where

  Hong Kong

  Age

  18 years and over

  People

  171 worldwide

  Run by

  Takeda

  See details and how to joinNCT06722235 · EU 2024-514401-54-00
• Phase 3Taking people
  A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  Where

  Hong Kong

  Age

  18 years and over

  People

  150 worldwide

  Run by

  Takeda

  See details and how to joinNCT06948318 · EU 2025-521692-31-00
• No phaseTaking people
  Safety and Efficacy of Fecal Microbiota Transplantation

  Where

  Hong Kong

  People

  450

  Run by

  Chinese University of Hong Kong

  See details and how to joinNCT04014413
• No phaseTaking people
  The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP

  Where

  Hong Kong

  Age

  15 years to 99 years

  People

  126 worldwide

  Run by

  Yunfeng Cheng

  See details and how to joinNCT06479291
• No phaseTaking people
  The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP

  Where

  Hong Kong

  Age

  15 years to 99 years

  People

  129 worldwide

  Run by

  Yunfeng Cheng

  See details and how to joinNCT06479304
• No phaseTaking people
  The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP

  Where

  Hong Kong

  Age

  15 years to 75 years

  People

  129 worldwide

  Run by

  Yunfeng Cheng

  See details and how to joinNCT06479317